Abstract
Introduction
2002 also revealed those in the whole country to be 4.0% and 15.5%, respectively [6] . Hence, rapid 56 identification of MDR-TB is crucial for proper treatment to avoid additional resistance development.
57
In this context, the molecular characterization of drug resistance by identifying mutations in 58 associated genes is applicable for developing potentially rapid molecular drug susceptibility tests as 59 an alternative to conventional methods.
60
A convergence of data from different countries has indicated that resistance to RIF in 78% -
61
100% of cases is due to mutations resulting in an amino acid substitution within the 81-bp core 62 region of the RNA polymerase β-subunit gene, or RIF resistance-determining region (RRDR) [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . 
Mutations in the rpoB gene

112
Mutations in the RRDR of the rpoB gene were identified in 127 isolates (Table 2) . A single 113 nucleotide alteration in codon 531, resulting in an amino acid substitution from Ser to Leu, was most 114 prevalent and observed in 84 isolates (47.2%). The second most affected codon was 526, which was 115 found in 25 isolates (14.0%) and showed six types of amino acid substitutions. Eight isolates had a 116 mutation in codon 533, six had a mutation in codon 516, two had a mutation in codon 513 and one 117 each in codons 510 and 517, respectively. Two of the isolates that had a mutation in codons 526, 516 118 6 and 533, also had an additional non-synonymous mutation in the RRDR ( KatG other than codon 315 were found in only one isolate: a Gly to Arg substitution at codon 285.
125
Mutations in the inhA regulatory region were observed in 20 (11.2%) MDR isolates, 18 of which had 126 a C to T mutation at position -15, one had a G to T change at position -17 and one had a C to T 127 mutation at position -15 in combination with a T to C mutation at position -8 (Table 3) . 
Frequencies of drug-resistance associating mutations
129
Frequencies of RIF-and INH-resistance associating mutations among the isolates in this study were 130 compered with those among isolates from surrounding countries and Myanmar as presented in Table   131 4 and 5, respectively, and the results of Fisher's exact test were shown in Table 6 respectively. Although the analysis seemed to be conclusive, the correlation rates between resistance 154 and mutations in these genes were lower than those reported in countries Myanmar The difference in the sample collection period might have affected the mutation detection rate.
168
Further, differences in the number of isolates analyzed in the previous study and ours ( (Fig. 1) . The distinct mutation pattern and mutation detection rate (Table 4) The 
